1st Quarter - Report

ADAPTIVE BIOTECHNOLOGIES for ADAPTIVE BIOTECHNOLOGIES

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6102 and S.3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions

LobbyistCovered position, as disclosed
PAMELA LYNN BRADLEY covered legislative branch official

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6102 (117th), S. 3404 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.